Mural Oncology plc - Ordinary shares, nominal value $0.01 per share (MURA)

Historical Holders from Q4 2023 to Q3 2025

Type / Class
Equity / Ordinary shares, nominal value $0.01 per share
Symbol
MURA
Shares outstanding
17,255,853
Price per share
$2.04
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
5,321,151
Total reported value
$11,013,094
% of total 13F portfolios
0%
Share change
-2,911,844
Value change
-$7,685,237
Number of holders
58
Price from insider filings
$2.04
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Mural Oncology plc - Ordinary shares, nominal value $0.01 per share (MURA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ACORN BIOVENTURES, L.P. 7.6% +22% $3,369,527 +$547,205 1,286,079 +19% Anders Hove 31 Dec 2024
FELDMAN STUART 4.4% $2,005,872 765,600 Stuart Feldman 16 Apr 2025
As of 30 Sep 2025, Mural Oncology plc - Ordinary shares, nominal value $0.01 per share (MURA) has 58 institutional shareholders filing 13F forms. They hold 5,321,151 shares. of 17,255,853 outstanding shares (31%) .

Top 25 institutional shareholders own 30% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
ORBIMED ADVISORS LLC 3.4% 588,800 0% 0.03% $1,218,816
Newtyn Management, LLC 3% 522,919 -8.3% 0.13% $1,082,442
OMERS ADMINISTRATION Corp 3% 511,000 0.01% $1,057,770
VANGUARD GROUP INC 2.6% 454,712 -41% 0% $941,254
Rangeley Capital, LLC 1.8% 305,000 +556% 0.61% $631,350
BlackRock, Inc. 1.7% 287,580 +0.41% 0% $595,290
RBF Capital, LLC 1.6% 283,912 0% 0.03% $587,698
MILLENNIUM MANAGEMENT LLC 1.5% 258,487 -18% 0% $535,068
CITADEL ADVISORS LLC 1.5% 258,250 +257% 0% $534,577
DELTEC ASSET MANAGEMENT LLC 1% 179,057 0.06% $370,648
GEODE CAPITAL MANAGEMENT, LLC 1% 175,111 +0.2% 0% $362,580
TORNO CAPITAL, LLC 0.99% 170,000 0.15% $351,900
Yakira Capital Management, Inc. 0.95% 163,954 0.13% $339,385
FNY Investment Advisers, LLC 0.85% 147,076 +3941% 0.1% $304,000
RENAISSANCE TECHNOLOGIES LLC 0.85% 146,000 +1137% 0% $302,220
MORGAN STANLEY 0.59% 102,173 +395% 0% $211,497
PRIMECAP MANAGEMENT CO/CA/ 0.54% 92,800 0% 0% $192,096
SIMPLEX TRADING, LLC 0.52% 90,256 +43% 0% $186,000
STATE STREET CORP 0.49% 84,873 0% 0% $175,687
PenderFund Capital Management Ltd. 0.48% 82,800 0.03% $171,396
BML Capital Management, LLC 0.33% 57,500 0.11% $119,025
Virtu Financial LLC 0.32% 55,721 0.01% $115,000
Shay Capital LLC 0.26% 45,088 0.02% $93,332
JANE STREET GROUP, LLC 0.24% 40,609 0% $84,061
DIMENSIONAL FUND ADVISORS LP 0.23% 39,822 -13% 0% $82,432

Institutional Holders of Mural Oncology plc - Ordinary shares, nominal value $0.01 per share (MURA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 5,321,151 $11,013,094 -$7,685,237 $2.07 58
2025 Q2 8,232,985 $20,335,094 +$3,120,880 $2.47 61
2025 Q1 8,395,072 $10,577,119 -$2,681,464 $1.26 62
2024 Q4 9,375,536 $30,188,503 -$4,619,940 $3.22 71
2024 Q3 9,521,654 $29,799,342 -$4,112,563 $3.13 69
2024 Q2 10,897,746 $34,217,578 -$6,397,175 $3.14 79
2024 Q1 12,252,400 $59,913,404 -$6,550,206 $4.89 94
2023 Q4 13,356,680 $79,068,382 +$79,068,258 $5.92 119